Nimesulide Ratiopharm

Nimesulide, the active ingredient in Nimesulide Ratiopharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It is used to relieve pain, reduce fever, and decrease inflammation in conditions such as osteoarthritis, dysmenorrhea, and acute musculoskeletal pain in adults.

GNH USA supplies Nimesulide Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory compliance across EU and global markets, and reliable distribution networks.

Nimesulide is an NSAID that reduces prostaglandin‑mediated inflammation and is indicated for several painful or febrile conditions. - Pain: provides symptomatic relief of mild to moderate acute pain. - Fever: lowers elevated body temperature associated with infectious or inflammatory states. - Osteoarthritis: alleviates joint pain and improves functional mobility. - Dysmenorrhea: reduces menstrual cramps and associated discomfort. - Inflammatory conditions: diminishes swelling and redness in acute musculoskeletal inflammation.

Nimesulide may cause a range of adverse reactions, from mild to severe, depending on individual susceptibility and duration of therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes without clinical symptoms. - Mild renal function changes.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or failure. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulceration or bleeding. - Acute renal failure or significant renal impairment. - Anaphylactic reactions. - Blood dyscrasias such as agranulocytosis.

Before prescribing Nimesulide, clinicians should evaluate patient‑specific risk factors and monitor relevant parameters. - Renal function: assess baseline kidney status and avoid in severe renal impairment. - Hepatic function: monitor liver enzymes; contraindicated in active liver disease. - Gastrointestinal risk: use cautiously in patients with a history of ulcers or bleeding. - Cardiovascular risk: consider alternatives for patients with established cardiovascular disease. - Pregnancy and lactation: avoid unless benefits clearly outweigh potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nimesulide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: additive ulcerogenic effect. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: potential for renal function decline. - SSRIs or SNRIs: modest increase in bleeding tendency. - Oral hypoglycemics: may affect blood glucose control. - Antihypertensives: monitor blood pressure for possible changes.